Journals / Çukurova Anestezi ve Cerrahi Bilimler Dergisi / 2025 / Cilt: 8 Sayı: 4

The Molecular Effect of Tubing Length in Cardiopulmonary Bypass on Coagulation Factors

Kardiyopulmoner Bypass’ta Tubing Hat Uzunluğunun Koagülasyon Faktörleri Üzerine Moleküler Etkisi

Bişar Amaç(HARRAN UNIVERSITY, FACULTY OF HEALTH SCIENCES)0000-0003-0320-4239
Murat Ziya Bağış(HARRAN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, DEPARTMENT OF CARDIOVASCULAR SURGERY)0000-0002-4088-7510
Murat Ersoy(UNIVERSITY OF HEALTH SCIENCES, ŞANLIURFA MEHMET AKİF İNAN HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, DEPARTMENT OF CARDIOVASCULAR SURGERY)0000-0001-9571-1072
Pages
443–448
Publication Date
2025-12-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This can be linked to molecular events such as thrombin production, platelet activation, and the release of endothelium-derived pro-inflammatory markers, providing an explanatory mechanism for the clinical outcomes of the study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Coagulation factors may be affected depending on the tubing line lengths of CPB.
📊
Key Findings & Data:The aim of this retrospective study was to evaluate the effect of CPB tubing line lengths on coagulation factors and to assess the relationship of these effects with bleeding and transfusion rates and early clinical outcomes.
💡
Conclusion & Impact:This can be linked to molecular events such as thrombin production, platelet activation, and the release of endothelium-derived pro-inflammatory markers, providing an explanatory mechanism for the clinical outcomes of the study.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:kardiyopulmoner baypas · pıhtılaşma faktörleri · tubing hatları

Abstract

Aim: Coagulation factors may be affected depending on the tubing line lengths of CPB. The aim of this retrospective study was to evaluate the effect of CPB tubing line lengths on coagulation factors and to assess the relationship of these effects with bleeding and transfusion rates and early clinical outcomes. Methods: In this planned retrospective study, after applying the exclusion criteria, the included patients were divided into two groups based on tubing line lengths. Those with shorter tubing line lengths were defined as Group 1 and those with longer tubing line lengths than the first group were defined as Group 2. Coagulation factors, bleeding and transfusion rates of the groups were compared and statistical analyses were performed. Results: Demographic, descriptive and preoperative data of the groups included in the study were similar (p>0.005). There was a statistically significant difference between the postoperative day 1 and early postoperative clinical outcomes including PT, PTT, INR, APTT.2, factor 4, platelets, haemoglobin, haematocrit, erythrocytes, postoperative bleeding rate, postoperative transfusion rate, postoperative intubation time and ICU length of stay (p 0.005). Conclusion: In this study, we found that tubing line lengths in CPB-guided cardiac surgery have effects on coagulation factors and also increase the postoperative bleeding rate and consequently increase the transfusion rate. The findings of this clinical study suggest that longer CPB tubing sets not only affect laboratory coagulation parameters but also trigger coagulation and inflammation pathways at the molecular level through blood-biomaterials interactions. This can be linked to molecular events such as thrombin production, platelet activation, and the release of endothelium-derived pro-inflammatory markers, providing an explanatory mechanism for the clinical outcomes of the study.

Özet

Amaç: Kardiyopulmoner bypass (KPB) sırasında kullanılan tubing line uzunluklarına bağlı olarak pıhtılaşma faktörleri etkilenebilmektedir. Bu retrospektif çalışmanın amacı, KPB’de kullanılan tubing line uzunluklarının pıhtılaşma faktörleri üzerindeki etkisini değerlendirmek ve bu etkilerin kanama, transfüzyon oranları ve erken klinik sonuçlarla ilişkisini araştırmaktır. Yöntem: Planlanan bu retrospektif çalışmada, dışlama kriterlerinin uygulanmasının ardından hastalar tubing line uzunluklarına göre iki gruba ayrılmıştır. Daha kısa tubing line uzunluğuna sahip olanlar Grup 1, daha uzun tubing line uzunluğuna sahip olanlar ise Grup 2 olarak tanımlanmıştır. Grupların pıhtılaşma faktörleri, kanama ve transfüzyon oranları karşılaştırılmış ve istatistiksel analizler yapılmıştır. Bulgular: Çalışmaya dâhil edilen grupların demografik, tanımlayıcı ve preoperatif verileri benzer bulunmuştur (p>0.005). Postoperatif 1. gün verileri ve erken postoperatif klinik sonuçlar açısından PT, PTT, INR, APTT.2, faktör 4, trombosit, hemoglobin, hematokrit, eritrosit, postoperatif kanama oranı, postoperatif transfüzyon oranı, postoperatif entübasyon süresi ve yoğun bakımda kalış süresi açısından istatistiksel olarak anlamlı fark saptanmıştır (p 0.005). Sonuç: Bu çalışmada, KPB eşliğinde gerçekleştirilen kalp cerrahisinde kullanılan tubing line uzunluklarının pıhtılaşma faktörleri üzerinde etkili olduğu, postoperatif kanama oranını ve buna bağlı olarak transfüzyon gereksinimini artırdığı saptanmıştır. Bu klinik çalışmanın bulguları, daha uzun tubing line setlerinin yalnızca laboratuvar pıhtılaşma parametrelerini etkilemekle kalmayıp, kan-biyomateryal etkileşimleri yoluyla moleküler düzeyde pıhtılaşma ve inflamasyon yollarını da tetiklediğini göstermektedir. Bu durum, trombin üretimi, trombosit aktivasyonu ve endotelden salınan proinflamatuvar belirteçlerin artışı gibi moleküler olaylarla ilişkilendirilebilir ve çalışmanın klinik sonuçlarını açıklayan bir mekanizma sunabilir.

🔖

Cite This Article

Amaç, B., Bağış, M. Z., Ersoy, M. (2025). The Molecular Effect of Tubing Length in Cardiopulmonary Bypass on Coagulation Factors. Çukurova Anestezi ve Cerrahi Bilimler Dergisi, Cilt: 8 Sayı: 4, 443–448. https://doi.org/10.36516/jocass.1803321

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lena T, Amabile A, Morrison A, Torregrossa G, Geirsson A, Tesler UF, et al. Gibbon and the development of the heart-lung machine: The beginnings of open cardiac surgery. J Card Surg. 2022;37(12):4199-4201. [Crossref]
  2. Passaroni AC, Silva MA, Yoshida WB. Cardiopulmonary bypass: development of John Gibbon's heart-lung machine. Rev Bras Cir Cardiovasc. 2015;30(2):235-245. [Crossref]
  3. Shimoda T, Liu C, Mathis BJ, Goto Y, Ageyama N, Kato H, et al. Effect of cardiopulmonary bypass on coagulation factors II, VII and X in a primate model: an exploratory pilot study. Interdiscip Cardiovasc Thorac Surg. 2023;37(6):ivad194. [Crossref]
  4. Karkouti K, McCluskey SA, Syed S, Pazaratz C, Poonawala H, Crowther MA. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study. Anesth Analg. 2010;110(6):1533-1540. [Crossref]
  5. Morinaga M, Yoshitani K, Ogata S, Fukushima S, Matsuda H. Association between intraoperative blood salvage and coagulation disorder after cardiopulmonary bypass. JA Clin Rep. 2024;10(1):5. [Crossref]
  6. Roberts A, Duncan EC, Hargrave P, Kingery DR, Barnes J, Horstemeyer DL, et al. Complications of Cardiopulmonary Bypass From an Anesthesia Perspective: A Clinical Review. HCA Healthc J Med. 2023;4(1):13-21. [Crossref]
  7. Hu Z, Xu J, Gong Y, Gan C, Jiang T, Wu X, et al. Non-anticoagulant factors affecting coagulation in the extracorporeal circulation circuit and the development of an individualized regional citrate anticoagulation protocol for hemodialysis: A real-world retrospective study. Int J Artif Organs. 2023;46(6):329-336. [Crossref]
  8. Hessel EA 2nd. What's New in Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2019;33(8):2296-2326. [Crossref]
  9. Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost. 2021;19(3):617-632. [Crossref]
  10. Bhirowo YP, Raksawardana YK, Setianto BY, Sudadi S, Tandean TN, Zaharo AF, et al. Hemolysis and cardiopulmonary bypass: meta-analysis and systematic review of contributing factors. J Cardiothorac Surg. 2023;18(1):291. [Crossref]
  11. Meesters MI, von Heymann C. Optimizing Perioperative Blood and Coagulation Management During Cardiac Surgery. Anesthesiol Clin. 2019;37(4):713-728. [Crossref]
  12. Larsson M, Nozohoor S, Ede J, Herou E, Ragnarsson S, Wierup P, et al. Biomarkers of inflammation and coagulation after minimally invasive mitral valve surgery: a prospective comparison to conventional surgery. Scand Cardiovasc J. 2024;58(1):2347293. [Crossref]
  13. Paparella D, Rotunno C, Guida P, Travascia M, De Palo M, Paradiso A, et al. Minimally invasive heart valve surgery: influence on coagulation and inflammatory response. Interact Cardiovasc Thorac Surg. 2017;25(2):225-232. [Crossref]
  14. Argiriadou H, Antonitsis P, Gkiouliava A, Papapostolou E, Deliopoulos A, Anastasiadis K. Minimal invasive extracorporeal circulation preserves coagulation integrity. Perfusion. 2022;37(3):257-265. [Crossref]
  15. Cheng T, Barve R, Cheng YWM, Ravendren A, Ahmed A, Toh S, et al. Conventional versus miniaturized cardiopulmonary bypass: A systematic review and meta-analysis. JTCVS Open. 2021;8:418-441. [Crossref]
  16. Momin A, Sharabiani M, Mulholland J, Yarham G, Reeves B, Anderson J, et al. Miniaturized cardiopulmonary bypass: the Hammersmith technique. J Cardiothorac Surg. 2013;8:143. [Crossref]